VBLT - Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2020 Results - Earnings Call Transcript

Vascular Biogenics Ltd. (VBLT) Q4 2020 Earnings Conference Call March 25, 2021, 08:30 AM ET Company Participants Lee Roth - IR Dror Harats - CEO Amos Ron - CFO Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Jonathan Aschoff - ROTH Capital Partners Jonathan Kreizman - Valore Research Presentation Operator Greetings. Welcome to the VBL Therapeutics Fourth Quarter and Full-Year 2020 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I’ll now turn the conference over to the VBL team. You may begin. Lee Roth Thank you, Shemali. Good morning everyone and once again thank you for joining us for today’s VBL Therapeutics fourth quarter and full-year 2020 financial results and corporate update conference call. Leading the call this morning will be Professor Dror Harats, Chief Executive Officer and Amos

For further details see:

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q4 2020 Results - Earnings Call Transcript